Search

Biotin, Milk, Antidepressant Alerts

From eNewsletter 6/27/2022

DID YOU KNOW that if you are still consuming milk products when it is contraindicated (for 60-70% of humans), you are taking unnecessary risks? A new study from Nutrients states that in addition to the typical symptoms from consuming milk, which include abdominal pain, bloating, flatulence, diarrhea, stomach rumbling, and less frequently nausea and vomiting, researchers found that in about 30% of cases, constipation is also an issue. More ominously, a study from American Journal of Clinical Nutrition found drinking milk increases a man’s risk of developing prostate cancer by approximately 25%. Researchers in British Journal of Nutrition followed a large group of Danish subjects over a 19 year span, exploring associations between intake of different dairy products and all-cause and cause-specific mortality. Intake of milk products in place of cheese was associated with a higher rate of death, cardiovascular disease mortality, and cancer mortality. There is no cogent argument for drinking milk at any age, but especially after puberty, even if it is considered "healthier" by being organic or grass-fed.

Announcements

Text Us If It Is Convenient! We encourage text messages at (847) 498-3422.

Our COVID-19 Vaccine Opinion The document can be found at this link.

Virus Prevention And Treatment Vaccines minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is here to stay. Moreover, it is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others. Continue your immune support year-round. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.

Post-COVID Syndrome 2.0 The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome 2.0 Action Plan for purchase, or free to paid members here (must use the password), can bring measurable improvement.

Have a happy, healthy day! Steve and Bonnie Minsky

In Today's Issue

  • Paid Member Content

  • Well Connect Feature: Does Your Vaccine(s) Work?

  • Did You Know? Supps: The Endometriosis Vitamins

  • Menu Savvy: Do Children Eat What They Like or Dislike?

  • Brand Buzz: Chickpea Puffs

  • Intelligently Active: Exercise for the Airways

  • Intelligently Active: TMS for MDD

  • Wild Card: How to Do We Keep BP IN Check?

  • eInspire: Napoleon Hill

  • Free Member Content

  • Did You Know?

  • Biotin | Antidepressant Alerts

  • July/June 20% OFF Sale Items

  • Pure Genomics

  • Watch - Vit D Genetic Traits

  • Loyalty Program

  • Well Connect Member Benefits

Buy One Year Paid Membership for $79.99*

ALERT: Biotin | Antidepressants Steve: There are two major public health issues you need to be aware of. Biotin May Create False Thyroid Readings There are several reasons why we suggest clients avoid taking supplements 24-48 hours prior to a blood test. One reason is that a sizable proportion of people who use cosmetic products and dietary supplements containing biotin may interfere with several laboratory measurements, including those of thyroid function, according to new research from the American Association of Clinical Endocrinology Annual Meeting 2022. It is now common practice that if an asymptomatic patient's thyroid test comes back suggesting hyperthyroidism, doctors and health professionals should ask if the patient has been using hair, skin, or nail products containing biotin. If you are taking biotin, we suggest stopping it 72 hours prior to your blood test just to be sure it has cleared your bloodstream. Get a Genetic Test Before Taking an Antidepressant We have many natural ways to support mood, but if medication is necessary for depression, there should be no reason to take anything unless you get a genetic test first. Genetic testing to determine the best antidepressant for patients with major depressive disorder (MDD) leads to an optimal drug choice on the first try and reduce healthcare costs, new research from European Psychiatric Association (EPA) 2022 Congress suggests. CYP2D6 and CYP2C19, from the cytochrome P450 family, are involved in the metabolism and elimination of various molecules, including medications. Variants in the genes encoding these enzymes affect the speed at which drugs are metabolized, altering their pharmacokinetic profiles. The researchers studied patients with MDD and used CYP2D6 and CYP2C19 genotyping to determine the presence of actionable phenotypes in line with US Food and Drug Administration labeling. They found that pharmacogenetic testing could have predicted poor response to the initial treatment selection and could have helped guide subsequent choices to improve outcomes. In addition, testing for functional variants in both genes would be cost-effective at a national level. FDA provides guidance on use of genetic testing on the labels of 34 psychiatric medications. Thus, do not take no for an answer if your doctor says that genetic testing is unnecessary. It is absolutely essential and demand that you are tested first.